Another company is having to recall products because of packaging issues which could lead to serious health consequences for patients. This time the mix-up could result in patients getting ibuprofen instead of their scheduled dose of a seizure drug prescribed for epilepsy patients.
American Health Packaging, a unit of wholesaler and drug services company AmerisourceBergen, is recalling one lot of 600-mg ibuprofen tablets in a hospital unit dose presentation and one lot of 300-mg oxcarbazepine tablets because there is a chance that tablets of each may have gotten in blister packs for the other. “This voluntary recall is the result of mislabeled inner unit dose blister packaging which could result in patients receiving ibuprofen and missing their scheduled dose of oxcarbazepine,” American Health said in a release.
